Combinatorial Biology: New Products and Processes from Genetic Diversity is a 120 page integrated market and technology report. The authors use a strong foundation of extensive research and analysis to generate 1999-2005 estimated market sizes for directed evolution of industrial enzymes, directed evolution of therapeutic proteins, combinatorial biosynthesis, and combinatorial tools for target discovery and validation. The authors use extensive primary research, including in-depth interviews with customers and company representatives. The market models are based on 5  evaluations: (1) Strengths and limitations of combinatorial biology technologies. (2) Opportunities and challenges in the market. (3) Major patent conflicts. (4) Technologies and business strategies of 13 leading combinatorial biology companies. And (5) positive and negative market drivers. Companies profiled in this report are: Applied Molecular Evolution, BioInvent, Cambridge Antibody Technology, Diversa, Enchira Biotechnology, Genencor International, Kosan Biosciences, Maxygen, MorphoSys, Novo Nordisk Biotech, Phylos, Rigel, and TerraGen Discovery (recently acquired by Cubist Pharmaceuticals).